Procyon Advisors’s Encompass Health EHC Stock Holding History

Procyon Advisors’s Portfolio EHC Stock Details EHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-4	Closed	–	–	426
2020 Q2	$0	Hold	4	–	–	﹤0.01%	1096
2020 Q1	$0	Buy	+4	New	+$231	﹤0.01%	1039

Other funds holding EHC

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Jana Partners New York $1.34B AUM 4.95% 1-Year Est. Return

Procyon Advisors's EHC Position: Q3 2020 in Review

Procyon Advisors sold out of Encompass Health (EHC) in Q3 2020, closing a stake of 4 shares.

Procyon Advisors first reported a position in EHC in Q1 2020 and held it in 2 quarters. The position peaked at $0 in Q2 2020. 380 funds tracked by Wall St. Rank hold EHC as of Q3 2020.

Procyon Advisors reported no remaining Encompass Health position as of Q3 2020 after selling out during the quarter.
Procyon Advisors sold 4 Encompass Health shares in Q3 2020.
Procyon Advisors first reported a position in Encompass Health in Q1 2020 and held it in 2 quarters.
Procyon Advisors's Encompass Health position peaked at $0 in Q2 2020.
380 funds tracked by Wall St. Rank held Encompass Health as of Q3 2020.

Based on Procyon Advisors's 13F filing for Q3 2020, filed 22 Oct 2020.